Max Wilmanns, Rechtsanwalt bei GSK Stockmann
31 March 2021

GSK Stockmann advises Element Materials Technology on the acquisition of KDK Kalibrierdienst Kopp

GSK Stockmann has advised Element Materials Technology Group on the acquisition of KDK Kalibrierdienst Kopp GmbH from Wiesloch near Heidelberg. The parties agreed to keep the purchase price confidential.

Headquartered in London, Element Materials Technology Group is one of the world’s leading providers of testing, inspection and certification services for a wide array of materials, products and technologies. Currently, the company employs more than 6,000 scientists, engineers and technicians at around 200 locations across five continents.

KDK Kalibrierdienst Kopp, based in Wiesloch near Heidelberg, is a market-leading German provider of calibration and measurement services. The company, which is accredited by the German National Accreditation Body DAkkS, works in particular for customers from the automotive industry and mechanical engineering in southern Germany. With this acquisition, Element expands the profile of calibration service provider Element Metech in Germany.

The advice provided by GSK Stockmann included a comprehensive due diligence as well as the negotiation and drafting of the complex share purchase agreement.

Advisors of Element Materials Technology Group:

GSK Stockmann: Max Wilmanns (lead, M&A), Philipp Kuhn (employment law), Jörg Kahler (IP and data protection), Wolfgang Jegodka (antitrust), Andreas Peters (M&A); Associates: Stephanie Löhrius (M&A), Nicole Deparade (employment law), Christina Reiber (real estate)

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 01 April 2021

    GSK Update: Federal Cabinet adopts Draft Bill for the Tax Haven Defence Act on 31 March 2021

    Read more
  • 31 March 2021

    GSK Update: Tax credit for foreign withholding tax on investment income against German trade tax

    Read more
  • 25 March 2021

    GSK Update: German Federal Ministry of Finance issues new circular on taxation of IP registered in Germany

    Read more
Contact person
Max Wilmanns GSK Stockmann

Max Wilmanns, LL.M.

Partner*

+49 40 369703-0

max.wilmanns@gsk.de

© GSK Stockmann 2021

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral